What does NaviFUS Corp. do?

NaviFUS Corp. (6872.TWO) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6872.TWO's market cap?

NaviFUS Corp. (6872.TWO) has a market capitalization of approximately $1.06 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 6872.TWO pay a dividend?

No — NaviFUS Corp. (6872.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is 6872.TWO profitable?

NaviFUS Corp. (6872.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

6872.TWO

NaviFUS Corp.

TWO·Medical, Devices · Healthcare

NT$15.05NT$0.30−1.95%

Market capNT$1.06B·Market closed·Aug 26 5:33 AM UTC

Price Chart

NT$15.05−NT$0.30 (−1.95%)today

−38.14%CAGR −10.87%

Select date range

FromTo

Jun 23, 2022Jun 23, 2022 → Aug 26, 2026· 4.2 yrsAug 26, 2026

Key Metrics

6872.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$27.25M

Net Income−NT$151.30M

Net Margin−555.2%

Operating Cash Flow−NT$78.28M

Capital ExpendituresNT$20.34M

Free Cash Flow−NT$98.62M

Return on Equity−31.1%

Return on Invested Capital−8.8%

Net CashNT$359.08M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6872.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6872.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6872.TWO and 80,000+ other tickers.

About NaviFUS Corp.

NaviFUS Corporation operates within the medical device sector, specializing in the development and commercialization of advanced focused ultrasound (FUS) technologies tailored for neurological applications. The company's primary offering is NaviFUS, a sophisticated transcranial FUS system precisely guided by neuronavigation. This innovative system is engineered to deliver concentrated energy to deep brain regions, supporting a range of clinical interventions such as enhanced drug delivery, neuromodulation, and immuno-stimulation. Additionally, NaviFUS Corp. provides NAVIRFA, a sophisticated…

CEO: Arthur Lung
Sector: Healthcare
Industry: Medical - Devices
Exchange: TWO
Employees: 20
Website: navifus.com

Peers

GeneReach Biotechnology Corp.

Cap

NT$994.2M

7427.TWO

Great Novel Therapeutics Biotech & Medicals

Cap

NT$4.0B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6872.TWO

What does NaviFUS Corp. do?: NaviFUS Corp. (6872.TWO) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6872.TWO's market cap?: NaviFUS Corp. (6872.TWO) has a market capitalization of approximately $1.06 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 6872.TWO pay a dividend?: No — NaviFUS Corp. (6872.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is 6872.TWO profitable?: NaviFUS Corp. (6872.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.